# STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Study · id `cardio:ct-nct05785897` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05785897](<https://clinicaltrials.gov/study/NCT05785897>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05785897

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

## Technical summary

Registry record NCT05785897. Randomized; single masking; primary purpose treatment. Start 2025-11-01 (actual); primary completion 2027-03-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT05785897, source copy `cardio:ctgov-nct05785897-2026-10-15`, retrieved 2026-11-18)
- Started: 2025-11-01 (actual) (ClinicalTrials.gov record NCT05785897, source copy `cardio:ctgov-nct05785897-2026-10-15`, retrieved 2026-11-18)
- Primary completion: 2027-03-01 (anticipated) (ClinicalTrials.gov record NCT05785897, source copy `cardio:ctgov-nct05785897-2026-10-15`, retrieved 2026-11-18)
- Completion: 2028-03-01 (anticipated) (ClinicalTrials.gov record NCT05785897, source copy `cardio:ctgov-nct05785897-2026-10-15`, retrieved 2026-11-18)
- Countries: Switzerland (ClinicalTrials.gov record NCT05785897, source copy `cardio:ctgov-nct05785897-2026-10-15`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05785897-2026-10-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
- Acronym: STARS DAPT
- Condition: ST Elevation Myocardial Infarction
- Intervention (Device): Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
- Lead sponsor: IGLESIAS Juan Fernando
- Lead sponsor class: OTHER
- Collaborator: Clinical Trials Unit University of Bern
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: f28b15b405cb9de33d704cf8d4203b5bb663fc05df1854887801e8f617e6f4e2
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
